Amerant Bancorp’s (AMTB) Overweight Rating Reiterated at Stephens

Amerant Bancorp (NASDAQ:AMTB)‘s stock had its “overweight” rating reaffirmed by equities researchers at Stephens in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $29.00 price objective on the stock. Stephens’ target price would suggest a potential upside of 19.10% from the stock’s previous close.

AMTB has been the topic of a number of other research reports. Raymond James cut their price target on shares of Amerant Bancorp from $27.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 2nd. Piper Sandler raised their price objective on Amerant Bancorp from $26.50 to $29.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th. Finally, Keefe, Bruyette & Woods lifted their target price on Amerant Bancorp from $24.00 to $28.00 and gave the stock a “market perform” rating in a report on Wednesday, December 4th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Amerant Bancorp has a consensus rating of “Moderate Buy” and a consensus target price of $27.20.

Amerant Bancorp Stock Up 8.7 %

Shares of NASDAQ:AMTB traded up $1.95 on Thursday, hitting $24.35. 58,218 shares of the company traded hands, compared to its average volume of 167,688. The company has a market cap of $1.03 billion, a PE ratio of -16.37 and a beta of 1.03. The stock has a 50 day simple moving average of $23.38 and a 200-day simple moving average of $22.29. Amerant Bancorp has a 52 week low of $18.54 and a 52 week high of $27.00. The company has a quick ratio of 0.94, a current ratio of 1.01 and a debt-to-equity ratio of 1.18.

Amerant Bancorp (NASDAQ:AMTB) last posted its quarterly earnings data on Wednesday, October 23rd. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.23 by $0.04. The firm had revenue of ($999.00) million for the quarter, compared to the consensus estimate of $99.39 million. Amerant Bancorp had a positive return on equity of 5.73% and a negative net margin of 8.38%. During the same quarter last year, the company earned $0.64 earnings per share. As a group, research analysts expect that Amerant Bancorp will post 1.19 earnings per share for the current year.

Institutional Investors Weigh In On Amerant Bancorp

A number of institutional investors and hedge funds have recently modified their holdings of AMTB. Creative Planning boosted its position in Amerant Bancorp by 7.6% during the third quarter. Creative Planning now owns 11,974 shares of the company’s stock worth $256,000 after purchasing an additional 850 shares during the period. JPMorgan Chase & Co. increased its position in Amerant Bancorp by 7.9% during the third quarter. JPMorgan Chase & Co. now owns 23,261 shares of the company’s stock worth $497,000 after acquiring an additional 1,705 shares during the period. The Manufacturers Life Insurance Company raised its stake in Amerant Bancorp by 23.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,998 shares of the company’s stock valued at $272,000 after purchasing an additional 2,316 shares during the last quarter. US Bancorp DE boosted its holdings in Amerant Bancorp by 655.8% in the 3rd quarter. US Bancorp DE now owns 3,212 shares of the company’s stock valued at $69,000 after purchasing an additional 2,787 shares during the period. Finally, Quantbot Technologies LP acquired a new stake in Amerant Bancorp in the 3rd quarter worth $65,000. Institutional investors and hedge funds own 42.11% of the company’s stock.

About Amerant Bancorp

Amerant Bancorp Inc operates as the bank holding company for Amerant Bank, N.A. that provides banking products and services to individuals and businesses in the United States and internationally. It offers checking, savings, business, and money market accounts; cash management services; and certificates of deposits.